-
AI & Machine Learning
How is Bio-GenAI transforming drug development Which segments of the value chain are already being d
...
-
AI & Machine Learning
Prerequisites/challenges associated with AI-driven de novo discovery of antigen-specific antibodies.
...
-
Bi/Multispecifics
How do you decide which bispecific format to use for a particular therapeutic goal? To what extent s
...
-
AI & Machine Learning
How does, or will, AI / ML improve antibody engineering? Will it become faster or more precise? How
...
-
Formats & Scaffolds
Nature of potential building blocks? How to assembly those building blocks? Which are the parameter
...
-
Lead Identification & Optimization
-
Lead Identification & Optimization
What are challenging targets? NGS + AI vs screening for candidate selection Antibody binding domains
...
-
Target Selection & Mechanisms of Action
-
Target Selection & Mechanisms of Action
There is a broad choice of formats and mode of actions for biologics, from simple IgGs to multispeci
...
-
Lead Identification & Optimization
-
Lead Identification & Optimization
Unlock the full potential of antibody engineering in just one visit. Our session showcases three tra
...
-
Bi/Multispecifics
Efficient bispecific antibody (bsAb) production requires precise assembly of multiple chains. Combin
...
-
Lead Identification & Optimization
-
Lead Identification & Optimization
Therapeutic antibodies—like other biotherapeutic proteins—can trigger unwanted immune responses, imp
...
-
Formats & Scaffolds
How can multispecific antibody fragments and scaffolds rival the well-established bispecific Antibod
...
-
Bi/Multispecifics
Target & Pathway Selection – What criteria should guide the choice of targets/biologies/pathways to
...
-
Lead Identification & Optimization
-
Lead Identification & Optimization
Can AI/ML really help to speed up antibody discovery (already)? How far can we get without a lab? Wh
...
-
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Target Selection & Mechanisms of Action
-
AI & Machine Learning
-
Lead Identification & Optimization
High-quality therapeutic antibodies aren’t the product of a single experiment, but of a series of cr
...
-
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Target Selection & Mechanisms of Action
-
AI & Machine Learning
-
Lead Identification & Optimization
Drinks-Canape Reception
-
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Target Selection & Mechanisms of Action
-
AI & Machine Learning
-
Lead Identification & Optimization
Afternoon Refreshments
-
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Target Selection & Mechanisms of Action
-
AI & Machine Learning
-
Lead Identification & Optimization
1-2-1 Meetings / Networking Break
-
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Target Selection & Mechanisms of Action
-
AI & Machine Learning
-
Lead Identification & Optimization
1-2-1 Meetings / Networking Break
-
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Target Selection & Mechanisms of Action
-
AI & Machine Learning
-
Lead Identification & Optimization
Networking Lunch
-
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Target Selection & Mechanisms of Action
-
AI & Machine Learning
-
Lead Identification & Optimization
Morning Refreshments
-
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Target Selection & Mechanisms of Action
-
AI & Machine Learning
-
Lead Identification & Optimization
1-2-1 Meetings / Networking Break
-
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Target Selection & Mechanisms of Action
-
AI & Machine Learning
-
Lead Identification & Optimization
1-2-1 Meetings / Networking Break
-
Bi/Multispecifics
How can bispecific antibodies be designed to achieve diverse modes of action such as antagonism, ago
...
-
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Target Selection & Mechanisms of Action
-
AI & Machine Learning
-
Lead Identification & Optimization
Bio-Rad’s Pioneer Antibody Discovery Platform includes one of the largest Fab libraries ever made, c
...
-
-
Bi/Multispecifics
-
Formats & Scaffolds
-
Target Selection & Mechanisms of Action
-
AI & Machine Learning
-
Lead Identification & Optimization
Registration
)
High-quality therapeutic antibodies aren’t the product of a single experiment, but of a series of cr ...)
Bio-Rad’s Pioneer Antibody Discovery Platform includes one of the largest Fab libraries ever made, c ...
)
)
)
)
)
)
)
)
)
)
)
)
